Los Angeles! FREE In-Person EB-5 Consultations on Jan 8th, 2025 - Register Now!

EB-5 Live Webinar

Join Our Live Webinar Covering How To Obtain a U.S. Green Card Through an $800,000 EB-5 Investment

Are you interested in obtaining a U.S. Green Card through the EB-5 investment program? We invite you to attend our upcoming live webinar, where we will delve into the benefits of the EB-5 program and how an $800,000 investment can help you and your family secure permanent residency in the United States.

Register Now

Event Details:

Location: Online at THIS LINK.
Date: Tuesday, November 26th, 2024
Time: 4:00 P.M. Eastern Standard Time

Mark your calendars, and don’t miss this opportunity to learn how the EB-5 program can open doors to U.S. residency for you and your family. We look forward to seeing you there!

Topics Covered:

Background of the EB-5 Program: Learn the history and purpose behind this investment-based immigration opportunity.
Current Trends in EB-5: Stay up to date with the latest developments, including changes in regulations and the current landscape for investors.
Introduction to LCP: Discover how LCP can guide you through the process, and explore some of our successful EB-5 projects.
Live Q&A: There will be a live Q&A session at the end of the webinar, so be sure to bring any questions you may have about the EB-5 program and the investment process.

We are excited to announce that Christian Triantaphyllis, an experienced immigration attorney from Jackson Walker LLP, will be present to provide valuable legal insights and answer your questions.

Event Presenters:

EB-5 Overview

Learn how the EB-5 investment program works.

Investment & Visa Process

Review the process and eligibility requirements.

EB-5 Questions and Answers

Get answers to commonly asked questions.

EB-5 Projects

Explore our successful EB-5 projects.

Relocation Services

Let us help you with your move to the United States.

EB-5 Resources

Research top universities, key professions, major cities, and more.

FEATURED LCP EB-5 PROJECT

ATTRACTIVE OPPORTUNITY IN COLORADO SPRINGS, COLORADO

LCP’s latest EB-5 project is a build-to-suit manufacturing facility in Colorado Springs, Colorado. An affiliate of LCP will acquire, develop and lease the property to a single tenant, bio365, for a 25-year term. Bio365 is a high growth, patented soil manufacturer for Controlled Environmental Agriculture (“CEA”) with a strong pipeline and high conversion rate and a clear path to growth.

The strategic location of Colorado Springs is home to diverse manufacturing facilities with over 400 manufacturers located in the region. Located in warehouse supply-constrained location, demand for light-industrial warehouses will continue to grow.

Aside from the positive macro trends, Colorado Springs also presents strong local fundamentals. It was voted the Most Desirable Place to Live by U.S. News & World Report in 2018 and 2019. A forecast by Realtor.com ranks Colorado Springs as No. 7 among the nation’s Top 10 housing markets for 2020. Colorado Springs is among the top cities for tech talent growth, ranked No. 4 on CBRE’s Annual List of Up-and-Coming Tech Markets.

PROJECT DETAILS

Project Type:

Single Tenant Net Lease

Project Sponsor:

The LCP Group L.P.

Tenant:

bio365

Lease Term:

25 Years

Construction start date:

Q4 2020

Construction end date:

Q3 2021

Minimum Investment Amount:

$800,000 USD for EB-5 investors; $100,000 USD for qualified U.S. or foreign investors

Total EB-5 Investment Amount:

$4,500,000

Investment Type:

Common Equity

Investment Term:

~10 Years

Targeted Internal Rate of Return:

between 13%-19%*

Job Creation:

86 jobs

Opportunity Zone Eligible:

Yes

Projected information subject to change. *The final IRR may differ from that of the projections based on several assumptions made by the GP, including but not limited to (i) the total amount raised in the Fund which may expand the number of projects the Fund can complete, (ii) the duration required to complete any particular project, (iii) the degree of leverage used across one or all projects, (iv) the capitalization rate and value of the asset at the time of exit, and (v) the value of the bio365 warrants at the time of exit).